Redcare Pharmacy N.V.
ISIN: NL0012044747 | Ticker: SAE | LEI: 529900JK6UXHY1YKZ082
Country: Germany
Redcare Pharmacy N.V. is a prominent and rapidly growing online pharmacy company based in the Netherlands. Established in 2001, the company has quickly become one of the leading players in the European e-commerce healthcare sector.
Redcare Pharmacy operates an online platform that offers a wide range of pharmaceutical and healthcare products, including prescription and over-the-counter medications, personal care items, vitamins and supplements, beauty products, and more. Customers can conveniently browse and order from their extensive product catalog, which encompasses both well-known brands and generic alternatives.
One of the key advantages of Redcare Pharmacy is its strong focus on customer convenience and service. Through its user-friendly website and mobile applications, the company provides a seamless and accessible shopping experience for customers across Europe.
2001
Served areaEurope
Headcount1,902
HeadquartersErik de Rodeweg 11-13, 5975 WD Sevenum (The Netherlands) – Germany
| Line item in (eur) | 01.01.2019 | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|
| Assets | N/A | 427,980,000.00 | 536,909,000.00 | 783,077.00 | 729,472.00 |
| Noncurrent Assets | N/A | 217,165,000.00 | 282,822,000.00 | 350,315.00 | 385,556.00 |
| Property Plant And Equipment | N/A | 13,178,000.00 | 74,545,000.00 | 78,261.00 | 85,435.00 |
| Intangible Assets Other Than Goodwill | N/A | N/A | N/A | 257,476.00 | 289,005.00 |
| Investment Accounted For Using Equity Method | N/A | 1,105,000.00 | 1,151,000.00 | 1,154,000.00 | N/A |
| Investments In Associates Accounted For Using Equity Method | N/A | N/A | N/A | 30.00 | 5.00 |
| Investments In Joint Ventures Accounted For Using Equity Method | N/A | N/A | N/A | 1,154.00 | 1,250.00 |
| Investments In Associates | N/A | 402,000.00 | 605,000.00 | 305,000.00 | N/A |
| Deferred Tax Assets | N/A | 120,000.00 | 120,000.00 | 0.00 | 462.00 |
| Other Noncurrent Financial Assets | N/A | 2,500,000.00 | 1,730,000.00 | 13,109.00 | 9,389.00 |
| Noncurrent Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income | N/A | N/A | N/A | 10.00 | 10.00 |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | N/A | 10,000.00 | 10,000.00 | 10,000.00 | N/A |
| Current Assets | N/A | 210,815,000.00 | 254,087,000.00 | 432,762.00 | 343,916.00 |
| Inventories | N/A | 56,688,000.00 | 81,240,000.00 | 96,624.00 | 99,708.00 |
| Trade And Other Current Receivables | N/A | 40,894,000.00 | 44,591,000.00 | 52,310.00 | 59,876.00 |
| Other Current Financial Assets | N/A | 50,581,000.00 | 37,771,000.00 | 36,415.00 | 117,555.00 |
| Cash and cash equivalents | 24,338,000.00 | 62,653,000.00 | 90,485.00 | 247,413.00 | 66,777.00 |
| Equity And Liabilities | N/A | 427,980,000.00 | 536,909,000.00 | 783,077.00 | 729,472.00 |
| Equity | 213,977,000.00 | 232,763,000.00 | 425,138.00 | 415,413.00 | 354,630.00 |
| Other Reserves | N/A | -108,429,000.00 | -126,881,000.00 | -151,485,000.00 | N/A |
| Noncurrent Liabilities | N/A | 135,417,000.00 | 37,157,000.00 | 243,580.00 | 255,536.00 |
| Deferred Tax Liabilities | N/A | 3,904,000.00 | 4,347,000.00 | 13,552.00 | 7,886.00 |
| Other Noncurrent Financial Liabilities | N/A | N/A | N/A | 230,028.00 | 247,650.00 |
| Current Liabilities | N/A | 59,801,000.00 | 74,614,000.00 | 124,085.00 | 119,306.00 |
| Trade And Other Current Payables | N/A | 32,004,000.00 | 53,147,000.00 | 80,523.00 | 72,882.00 |
| Other Current Financial Liabilities | N/A | N/A | N/A | 6,368.00 | 7,505.00 |
| Other Current Nonfinancial Liabilities | N/A | N/A | N/A | 37,156.00 | 38,879.00 |
| Other Current Liabilities | N/A | 10,108,000.00 | 16,044,000.00 | 37,156,000.00 | N/A |
| Line item in (eur) | 01.01.2019/ 01.01.2020 |
01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|---|
| Revenue | 701,010,000.00 | 968,062,000.00 | 1,060,321.00 | 1,204,352.00 |
| Other Income | 736,000.00 | 65,000.00 | 160.00 | 149.00 |
| Profit Loss From Operating Activities | -33,445,000.00 | -866,000.00 | -65,698.00 | -69,172.00 |
| Finance Income | 1,333,000.00 | 93,000.00 | 1,519.00 | 2,075.00 |
| Finance Costs | 10,171,000.00 | 15,204,000.00 | 13,278.00 | 17,361.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | 104,000.00 | 45,000.00 | -427.00 | 339.00 |
| Profit Loss Before Tax | -42,180,000.00 | -15,932,000.00 | -77,884.00 | -84,119.00 |
| Income Tax Expense Continuing Operations | -5,910,000.00 | 839,000.00 | -3,699.00 | -6,473.00 |
| Profit (loss) | -36,270,000.00 | -16,771,000.00 | -74,185.00 | -77,646.00 |
| Profit Loss Attributable To Owners Of Parent | -36,270,000.00 | -16,771,000.00 | -74,185.00 | -77,646.00 |
| Line item in (eur) | 01.01.2019 | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|
| Profit (loss) | N/A | -36,270,000.00 | -16,771,000.00 | -74,185.00 | -77,646.00 |
| Adjustments For Income Tax Expense | N/A | 4,000.00 | -329,000.00 | -179.00 | -457.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -13,339,000.00 | -24,552,000.00 | -15,375.00 | -3,084.00 |
| Adjustments For Increase Decrease In Trade Account Payable | N/A | N/A | 21,076,000.00 | 26,507,000.00 | N/A |
| Adjustments For Increase Decrease In Other Operating Payables | N/A | N/A | 5,936,000.00 | 23,967,000.00 | N/A |
| Adjustments For Depreciation And Amortisation Expense | N/A | 14,864,000.00 | 16,064,000.00 | 26,964.00 | 39,510.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | N/A | -29,000.00 | -234,000.00 | 1,488.00 | 1,762.00 |
| Adjustments For Sharebased Payments | N/A | 2,967,000.00 | 4,405,000.00 | 20,542.00 | 16,226.00 |
| Interest Received Classified As Operating Activities | N/A | 1,333,000.00 | 93,000.00 | N/A | N/A |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | N/A | 329,000.00 | 179,000.00 | N/A |
| Cash Flows From Used In Operating Activities | N/A | -30,728,000.00 | 17,802,000.00 | 11,635.00 | -29,112.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | N/A | 0.00 | 31,181.00 | 6,017.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 4,003,000.00 | 38,235,000.00 | 13,818.00 | 13,565.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | 10,739,000.00 | 15,100,000.00 | 29,341.00 | 39,959.00 |
| Interest Received Classified As Investing Activities | N/A | N/A | 93,000.00 | 31.00 | 313.00 |
| Cash Flows From Used In Investing Activities | N/A | -33,400,000.00 | -40,164,000.00 | -84,297.00 | -138,009.00 |
| Proceeds From Issuing Shares | N/A | 49,148,000.00 | 63,381,000.00 | 0.00 | N/A |
| Proceeds From Borrowings Classified As Financing Activities | N/A | N/A | 0.00 | 13,000,000.00 | N/A |
| Repayments Of Borrowings Classified As Financing Activities | N/A | N/A | 37,000.00 | 5,663,000.00 | N/A |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 2,456,000.00 | 2,362,000.00 | 5,784.00 | 5,461.00 |
| Interest Paid Classified As Financing Activities | N/A | N/A | N/A | 6,377.00 | 7,068.00 |
| Cash Flows From Used In Financing Activities | N/A | 102,442,000.00 | 50,193,000.00 | 229,590.00 | -13,515.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 38,314,000.00 | 27,831,000.00 | 156,928,000.00 | N/A |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | 0.00 | 0.00 | 0.00 | N/A |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | N/A | N/A | 156,928.00 | -180,636.00 |
| Cash and cash equivalents | 24,338,000.00 | 62,653,000.00 | 90,485.00 | 247,413.00 | 66,777.00 |
Please note that some sums might not add up.
NL0012044747
LEI529900JK6UXHY1YKZ082
SectorHealth Care Equipment & Services
IndustryHealth Care Providers & Services
Sub-IndustryMDAX
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.